About Index Trending news
Analyze
Pricing

Pharmaceuticals

400+ Companies
Investor Country City Investments Total amount raised
United States Boston 267 $ 6,162.4M
- San Mateo 63 $ 1,714.3M
OrbiMed

OrbiMed

- - 34 $ 1,485.0M
United States Menlo Park 41 $ 1,304.6M
Alexandria Venture

Alexandria Venture

- - 10 $ 322.8M
United States New York 112 $ 1,976.0M
- - 19 $ 431.7M
United States Seattle 38 $ 1,552.5M
United States Menlo Park 736 $ 30,073,107,921
United States Chicago 98 $ 2,593.3M
Denmark - 25 $ 1,907.5M
- - 32 $ 1,884.9M
United States Menlo Park 21 $ 673.6M
United States New York 32 $ 1,165.8M
United Kingdom - 284 $ 5,258.6M
France Paris 31 $ 329.1M
United States Cambridge 30 $ 1,026.4M
United States Austin 93 $ 3,695.5M
United States Boston 39 $ 691.0M
United States San Francisco 173 $ 2,097.2M
- - 19 $ 1,249.5M
China Shanghai 3 $ 136.4M
Vivo Capital

Vivo Capital

- - 10 $ 416.0M
AbbVie Biotech Ventures

AbbVie Biotech Ventures

- - 5 $ 191.0M
Watson Fund

Watson Fund

- - 1 $ 7.0M
United States New York 188 $ 16,398,719,440
- - 47 $ 1,385.5M
United States Palo Alto 101 $ 1,880.6M
United States Boston 40 $ 1,513.9M
Accuitive Medical Ventures

Accuitive Medical Ventures

- - 12 $ 296.5M
WRF Capital

WRF Capital

- - 15 $ 162.8M
United States - 4 $ 134.5M
Accelerator Corporation

Accelerator Corporation

- - 1 $ 7.0M
United States Menlo Park 113 $ 2,207.1M
Australia Melbourne 27 $ 163.3M
CRG L.P.

CRG L.P.

- - 3 $ 210.0M
Vatera Healthcare Partners

Vatera Healthcare Partners

- - 5 $ 217.0M
Arcapita Ventures

Arcapita Ventures

- - 6 $ 123.5M
United Kingdom - 35 $ 106.2M
SCP Vitalife Partners

SCP Vitalife Partners

- - 6 $ 138.0M
The Netherlands - 16 $ 511.5M
United States Cambridge 87 $ 2,209.9M
United States Menlo Park 171 $ 3,228.0M
United States Cambridge 255 $ 3,221.8M
United States San Francisco 27 $ 1,312.6M
Germany Munich 27 $ 601.3M
United States New York 63 $ 2,334.8M
United States - 30 $ 1,498.6M
Latterell Venture Partners

Latterell Venture Partners

- - 13 $ 249.6M
- - 39 $ 1,153.9M
Showing a curated sample of 50 investors in the Pharmaceuticals market.

Want to see the complete list?
Go Pro!